Effects of estrogen or estrogen/progestin regimens on heart disease risk factors in postmenopausal women. The Postmenopausal Estrogen/Progestin Interventions (PEPI) Trial. The Writing Group for the PEPI TrialValery T. Miller, Sally A. Shumaker, John C. LaRosa et al.|JAMA|1995Cited by 605
Estrogen Plus Progestin and Breast Cancer Incidence and Mortality in Postmenopausal WomenRowan T. Chlebowski, for the WHI Investigators, Judith K. Ockene et al.|JAMA|2010Cited by 565
Breast Cancer after Use of Estrogen plus Progestin in Postmenopausal WomenRowan T. Chlebowski, Garnet L. Anderson, Lewis H. Kuller et al.|New England Journal of Medicine|2009Cited by 468
Conjugated equine oestrogen and breast cancer incidence and mortality in postmenopausal women with hysterectomy: extended follow-up of the Women's Health Initiative randomised placebo-controlled trialGarnet L. Anderson, Jean Wactawski‐Wende, Rowan T. Chlebowski et al.|The Lancet Oncology|2012Cited by 360